Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Memorial Sloan Kettering Cancer Center
Quadriga Biosciences, Inc.
Case Comprehensive Cancer Center
Tocagen Inc.
National Cancer Institute (NCI)
Children's Oncology Group
INSYS Therapeutics Inc
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Duke University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Siemens Molecular Imaging